Opportunity ID: 361213
General Information
| Funding Opportunity Number | RFA-DK-27-112 |
| Funding Opportunity Title | Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) |
| Agency | National Institutes of Health |
| Document Type | synopsis |
| Version | 1 |
| Opportunity Category | Discretionary |
| Opportunity Category Explanation | Not specified |
| Funding Instrument Type | Cooperative Agreement |
| Category of Funding Activity | Health |
| Category Explanation | Not specified |
| Expected Number of Awards | 1 |
| Cost Sharing or Matching Requirement | No |
| Posted Date | Aug 31, 2026 12:00:00 AM EDT |
| Last Updated Date | Aug 31, 2026 10:20:25 AM EDT |
| Original Closing Date | Nov 09, 2026 12:00:00 AM EST |
| Original Closing Date Notes | Not specified |
| Current Closing Date | Nov 09, 2026 12:00:00 AM EST |
| Current Closing Date Notes | Not specified |
| Estimated Synopsis Date | Not specified |
| Estimated Application Due Date | Not specified |
| Estimated Award Date | Not specified |
| Estimated Project Start Date | Not specified |
| Archive Date | Jan 08, 2027 12:00:00 AM EST |
| Estimated Total Program Funding | 6,300,000 |
| Award Ceiling | none |
| Award Floor | none |
Assistance Listings
- 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Eligibility
| Eligible Applicants | Others (see text field entitled "Additional Information on Eligibility" for clarification) |
This is a Forecast for a single source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.
Description
This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite an application from the eligible organization to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, applications will be peer-reviewed, and only meritorious applications will be considered for funding. Through this NOFO, the National institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites an application to continue to follow the Epidemiology of Diabetes Interventions and Complications (EDIC) cohort through a collaborative cooperative agreement that addresses specific knowledge gaps in the development and progression of type 1 diabetes complications. Applications should include hypothesis-based research, support for cohort infrastructure and/or maintenance, continued follow-up, and supporting collaborative research to utilize the EDIC cohort as well as its data set and biologic/genetic samples.
Additional Information
| Contact | National Institutes of Health |
| Contact Information | Division of Diabetes, Endocrinology and Metabolic Diseases NIDDK_DEM@nih.gov |
| NIDDK_DEM@nih.gov | |
| Email Description | NIDDK_DEM@nih.gov |
| Phone | 301-402-2541 |
Additional information
Version History
Version history
| Opp hist id / Opportunity id | 361213 |
| Opp hist id / Revision | 1 |
| Opportunity id | 361213 |
| Revision | 1 |
| Opportunity number | RFA-DK-27-112 |
| Opportunity title | Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) |
| Owning agency code | HHS-NIH11 |
| Opportunity category / Category | D |
| Opportunity category / Description | Discretionary |
| Forecast / Opp hist id / Opportunity id | 361213 |
| Forecast / Opp hist id / Revision | 1 |
| Forecast / Opportunity id | 361213 |
| Forecast / Revision | 1 |
| Forecast / Version | 1 |
| Forecast / Posting date | Jan 29, 2026 12:00:00 AM EST |
| Forecast / Forecast desc | The primary purpose of this FOA is to support the EDIC Research Center in continuing long-term follow-up of the EDIC cohort to study the development and progression of complications in type 1 diabetes (T1D). The research will address severe microvascular disease, cardiovascular and liver disease, sleep disorders, mortality, and other comorbidities. The goals are to investigate the trajectory of age-related morbidities such as cognition, physical function, and frailty, and to identify their associations with risk factors that affect quality of life, self-management, and caregiver burden. Particular emphasis will be placed on evaluating the impact of emerging therapies, including SGLT2 inhibitors and GLP-1 receptor agonists, on renal and cardiovascular outcomes. The initiative also encourages the application of advanced statistical methods, including machine learning and artificial intelligence, to identify phenotypes that are either susceptible or resilient to diabetes-related complications. Modern technologies, such as continuous glucose monitoring, coronary calcification imaging, and vascular tonometry, will be used and compared with data from existing cohorts. In addition, the program will support assessments of obesity-related outcomes and comorbidities—including metabolic-associated steatotic liver disease (MASLD) and obstructive sleep apnea (OSA)—within the increasingly overweight/obese T1D population. Multi-omic approaches to identify biochemical signatures associated with complications are also expected. Finally, the leveraging of external databases to examine the cost-effectiveness and quality-of-life impact of intensive therapy across the lifespan will be encouraged. This is a Forecast for a single source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding. |
| Forecast / Cost sharing | No |
| Forecast / Number of awards | 1 |
| Forecast / Estimated funding | 6300000 |
| Forecast / Agency contact name | Division of Diabetes, Endocrinology and Metabolic Diseases |
| Forecast / Agency contact phone | NIDDK_DEM@nih.gov |
| Forecast / Agency contact email | NIDDK_DEM@nih.gov |
| Forecast / Agency contact email desc | NIDDK_DEM@nih.gov |
| Forecast / Agency code | HHS-NIH11 |
| Forecast / Applicant eligibility desc | This is a Forecast for a single source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding. |
| Forecast / Est synopsis posting date | Apr 01, 2026 12:00:00 AM EDT |
| Forecast / Est application response date | Jul 01, 2026 12:00:00 AM EDT |
| Forecast / Est award date | Oct 01, 2026 12:00:00 AM EDT |
| Forecast / Est project start date | Jul 01, 2027 12:00:00 AM EDT |
| Forecast / Fiscal year | 2027 |
| Forecast / Create time stamp | Jan 29, 2026 12:18:30 PM EST |
| Forecast / Action type | U |
| Forecast / Action date | Aug 31, 2026 10:20:25 AM EDT |
| Forecast / Created date | Jan 29, 2026 12:18:30 PM EST |
| Forecast / Last updated date | Jan 29, 2026 12:18:30 PM EST |
| Forecast / Agency details / Code | NIH |
| Forecast / Agency details / Seed | HHS-NIH11 |
| Forecast / Agency details / Agency name | National Institutes of Health |
| Forecast / Agency details / Agency code | HHS-NIH11 |
| Forecast / Agency details / Top agency code | HHS |
| Forecast / Estimated funding formatted | 6,300,000 |
| Forecast / Applicant types 1 / Id | 06 |
| Forecast / Applicant types 1 / Description | Public and State controlled institutions of higher education |
| Forecast / Applicant types 2 / Id | 20 |
| Forecast / Applicant types 2 / Description | Private institutions of higher education |
| Forecast / Funding instruments 1 / Id | CA |
| Forecast / Funding instruments 1 / Description | Cooperative Agreement |
| Forecast / Funding activity categories 1 / Id | HL |
| Forecast / Funding activity categories 1 / Description | Health |
| Forecast / Posting date str | 2026-01-29-00-00-00 |
| Forecast / Est synopsis posting date str | 2026-04-01-00-00-00 |
| Forecast / Est application response date str | 2026-07-01-00-00-00 |
| Forecast / Est award date str | 2026-10-01-00-00-00 |
| Forecast / Est project start date str | 2027-07-01-00-00-00 |
| Forecast / Create time stamp str | 2026-01-29-12-18-30 |
| Cfdas 1 / Id | 431845 |
| Cfdas 1 / Opportunity id | 361213 |
| Cfdas 1 / Revision | 0 |
| Cfdas 1 / Cfda number | 93.847 |
| Cfdas 1 / Program title | Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Synopsis modified fields | Not specified |
| Forecast modified fields | Not specified |
Forecast changes
revision
version
archiveDate
modComments
createTimeStamp
| Id | 361213 |
| Revision | 2 |
| Opportunity number | RFA-DK-27-112 |
| Opportunity title | Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) |
| Owning agency code | HHS-NIH11 |
| Opportunity category / Category | D |
| Opportunity category / Description | Discretionary |
| Synopsis / Opportunity id | 361213 |
| Synopsis / Version | 1 |
| Synopsis / Agency code | HHS-NIH11 |
| Synopsis / Agency name | National Institutes of Health |
| Synopsis / Agency phone | 301-402-2541 |
| Synopsis / Agency address desc | NIDDK_DEM@nih.gov |
| Synopsis / Agency details / Code | NIH |
| Synopsis / Agency details / Seed | HHS-NIH11 |
| Synopsis / Agency details / Agency name | National Institutes of Health |
| Synopsis / Agency details / Agency code | HHS-NIH11 |
| Synopsis / Agency details / Top agency code | HHS |
| Synopsis / Top agency details / Code | HHS |
| Synopsis / Top agency details / Seed | HHS |
| Synopsis / Top agency details / Agency name | Department of Health and Human Services |
| Synopsis / Top agency details / Agency code | HHS |
| Synopsis / Top agency details / Top agency code | HHS |
| Synopsis / Agency contact phone | 301-402-2541 |
| Synopsis / Agency contact name | National Institutes of Health |
| Synopsis / Agency contact desc | Division of Diabetes, Endocrinology and Metabolic Diseases NIDDK_DEM@nih.gov |
| Synopsis / Agency contact email | NIDDK_DEM@nih.gov |
| Synopsis / Agency contact email desc | NIDDK_DEM@nih.gov |
| Synopsis / Synopsis desc | This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite an application from the eligible organization to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, applications will be peer-reviewed, and only meritorious applications will be considered for funding. Through this NOFO, the National institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites an application to continue to follow the Epidemiology of Diabetes Interventions and Complications (EDIC) cohort through a collaborative cooperative agreement that addresses specific knowledge gaps in the development and progression of type 1 diabetes complications. Applications should include hypothesis-based research, support for cohort infrastructure and/or maintenance, continued follow-up, and supporting collaborative research to utilize the EDIC cohort as well as its data set and biologic/genetic samples. |
| Synopsis / Response date | Nov 09, 2026 12:00:00 AM EST |
| Synopsis / Posting date | Aug 31, 2026 12:00:00 AM EDT |
| Synopsis / Archive date | Jan 08, 2027 12:00:00 AM EST |
| Synopsis / Cost sharing | No |
| Synopsis / Number of awards | 1 |
| Synopsis / Estimated funding | 6300000 |
| Synopsis / Estimated funding formatted | 6,300,000 |
| Synopsis / Award ceiling | none |
| Synopsis / Award floor | none |
| Synopsis / Applicant eligibility desc | This is a Forecast for a single source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors. |
| Synopsis / Create time stamp | Aug 31, 2026 10:20:35 AM EDT |
| Synopsis / Created date | Aug 31, 2026 10:20:25 AM EDT |
| Synopsis / Last updated date | Aug 31, 2026 10:20:25 AM EDT |
| Synopsis / Applicant types 1 / Id | 25 |
| Synopsis / Applicant types 1 / Description | Others (see text field entitled "Additional Information on Eligibility" for clarification) |
| Synopsis / Funding instruments 1 / Id | CA |
| Synopsis / Funding instruments 1 / Description | Cooperative Agreement |
| Synopsis / Funding activity categories 1 / Id | HL |
| Synopsis / Funding activity categories 1 / Description | Health |
| Synopsis / Response date str | 2026-11-09-00-00-00 |
| Synopsis / Posting date str | 2026-08-31-00-00-00 |
| Synopsis / Archive date str | 2027-01-08-00-00-00 |
| Synopsis / Create time stamp str | 2026-08-31-10-20-35 |
| Agency details / Code | NIH |
| Agency details / Seed | HHS-NIH11 |
| Agency details / Agency name | National Institutes of Health |
| Agency details / Agency code | HHS-NIH11 |
| Agency details / Top agency code | HHS |
| Top agency details / Code | HHS |
| Top agency details / Seed | HHS |
| Top agency details / Agency name | Department of Health and Human Services |
| Top agency details / Agency code | HHS |
| Top agency details / Top agency code | HHS |
| Forecast / Opportunity id | 361213 |
| Forecast / Version | 2 |
| Forecast / Posting date | Jan 29, 2026 12:00:00 AM EST |
| Forecast / Archive date | Aug 30, 2026 12:00:00 AM EDT |
| Forecast / Forecast desc | The primary purpose of this FOA is to support the EDIC Research Center in continuing long-term follow-up of the EDIC cohort to study the development and progression of complications in type 1 diabetes (T1D). The research will address severe microvascular disease, cardiovascular and liver disease, sleep disorders, mortality, and other comorbidities. The goals are to investigate the trajectory of age-related morbidities such as cognition, physical function, and frailty, and to identify their associations with risk factors that affect quality of life, self-management, and caregiver burden. Particular emphasis will be placed on evaluating the impact of emerging therapies, including SGLT2 inhibitors and GLP-1 receptor agonists, on renal and cardiovascular outcomes. The initiative also encourages the application of advanced statistical methods, including machine learning and artificial intelligence, to identify phenotypes that are either susceptible or resilient to diabetes-related complications. Modern technologies, such as continuous glucose monitoring, coronary calcification imaging, and vascular tonometry, will be used and compared with data from existing cohorts. In addition, the program will support assessments of obesity-related outcomes and comorbidities—including metabolic-associated steatotic liver disease (MASLD) and obstructive sleep apnea (OSA)—within the increasingly overweight/obese T1D population. Multi-omic approaches to identify biochemical signatures associated with complications are also expected. Finally, the leveraging of external databases to examine the cost-effectiveness and quality-of-life impact of intensive therapy across the lifespan will be encouraged. This is a Forecast for a single source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding. |
| Forecast / Cost sharing | No |
| Forecast / Number of awards | 1 |
| Forecast / Estimated funding | 6300000 |
| Forecast / Agency contact name | Division of Diabetes, Endocrinology and Metabolic Diseases |
| Forecast / Agency contact phone | NIDDK_DEM@nih.gov |
| Forecast / Agency contact email | NIDDK_DEM@nih.gov |
| Forecast / Agency contact email desc | NIDDK_DEM@nih.gov |
| Forecast / Agency code | HHS-NIH11 |
| Forecast / Applicant eligibility desc | This is a Forecast for a single source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding. |
| Forecast / Est synopsis posting date | Apr 01, 2026 12:00:00 AM EDT |
| Forecast / Est application response date | Jul 01, 2026 12:00:00 AM EDT |
| Forecast / Est award date | Oct 01, 2026 12:00:00 AM EDT |
| Forecast / Est project start date | Jul 01, 2027 12:00:00 AM EDT |
| Forecast / Fiscal year | 2027 |
| Forecast / Mod comments | Updated Archive Date |
| Forecast / Create time stamp | Aug 31, 2026 10:20:35 AM EDT |
| Forecast / Created date | Jan 29, 2026 12:18:30 PM EST |
| Forecast / Last updated date | Aug 31, 2026 10:20:35 AM EDT |
| Forecast / Agency details / Code | NIH |
| Forecast / Agency details / Seed | HHS-NIH11 |
| Forecast / Agency details / Agency name | National Institutes of Health |
| Forecast / Agency details / Agency code | HHS-NIH11 |
| Forecast / Agency details / Top agency code | HHS |
| Forecast / Estimated funding formatted | 6,300,000 |
| Forecast / Applicant types 1 / Id | 20 |
| Forecast / Applicant types 1 / Description | Private institutions of higher education |
| Forecast / Applicant types 2 / Id | 06 |
| Forecast / Applicant types 2 / Description | Public and State controlled institutions of higher education |
| Forecast / Funding instruments 1 / Id | CA |
| Forecast / Funding instruments 1 / Description | Cooperative Agreement |
| Forecast / Funding activity categories 1 / Id | HL |
| Forecast / Funding activity categories 1 / Description | Health |
| Forecast / Posting date str | 2026-01-29-00-00-00 |
| Forecast / Archive date str | 2026-08-30-00-00-00 |
| Forecast / Est synopsis posting date str | 2026-04-01-00-00-00 |
| Forecast / Est application response date str | 2026-07-01-00-00-00 |
| Forecast / Est award date str | 2026-10-01-00-00-00 |
| Forecast / Est project start date str | 2027-07-01-00-00-00 |
| Forecast / Create time stamp str | 2026-08-31-10-20-35 |
| Synopsis attachment folders 1 / Id | 81208 |
| Synopsis attachment folders 1 / Opportunity id | 361213 |
| Synopsis attachment folders 1 / Folder type | Full Announcement |
| Synopsis attachment folders 1 / Folder name | Full Announcement |
| Synopsis attachment folders 1 / Zip lob size | 30877 |
| Synopsis attachment folders 1 / Created date | Aug 31, 2026 10:20:34 AM EDT |
| Synopsis attachment folders 1 / Last updated date | Aug 31, 2026 10:20:35 AM EDT |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Id | 354874 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Opportunity id | 361213 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Mime type | text/html;charset=UTF-8 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File name | RFA-DK-27-112-Full-Announcement.html |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File description | RFA-DK-27-112-Full-Announcement.html |
| Synopsis attachment folders 1 / Synopsis attachments 1 / File lob size | 136225 |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Created date | Aug 31, 2026 10:20:35 AM EDT |
| Synopsis attachment folders 1 / Synopsis attachments 1 / Synopsis att folder id | 81208 |
| Synopsis document urls | Not specified |
| Syn att change comments | Not specified |
| Cfdas 1 / Id | 431845 |
| Cfdas 1 / Opportunity id | 361213 |
| Cfdas 1 / Cfda number | 93.847 |
| Cfdas 1 / Program title | Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Opportunity pkgs 1 / Id | 294084 |
| Opportunity pkgs 1 / Topportunity id | 361213 |
| Opportunity pkgs 1 / Family id | 14 |
| Opportunity pkgs 1 / Dialect | XFDL2.2 |
| Opportunity pkgs 1 / Opportunity number | RFA-DK-27-112 |
| Opportunity pkgs 1 / Opportunity title | Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) |
| Opportunity pkgs 1 / Cfda number | 93.847 |
| Opportunity pkgs 1 / Opening date | 2026-10-09 |
| Opportunity pkgs 1 / Closing date | 2026-11-09 |
| Opportunity pkgs 1 / Owning agency code | HHS-NIH11 |
| Opportunity pkgs 1 / Agency details / Code | NIH |
| Opportunity pkgs 1 / Agency details / Seed | HHS-NIH11 |
| Opportunity pkgs 1 / Agency details / Agency name | National Institutes of Health |
| Opportunity pkgs 1 / Agency details / Agency code | HHS-NIH11 |
| Opportunity pkgs 1 / Agency details / Top agency code | HHS |
| Opportunity pkgs 1 / Top agency details / Code | HHS |
| Opportunity pkgs 1 / Top agency details / Seed | HHS |
| Opportunity pkgs 1 / Top agency details / Agency name | Department of Health and Human Services |
| Opportunity pkgs 1 / Top agency details / Agency code | HHS |
| Opportunity pkgs 1 / Top agency details / Top agency code | HHS |
| Opportunity pkgs 1 / Program title | Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Opportunity pkgs 1 / Contact info | eRA Service Desk https://www.era.nih.gov/need-help |
| Opportunity pkgs 1 / Grace period | 60 |
| Opportunity pkgs 1 / Competition id | FORMS-I |
| Opportunity pkgs 1 / Competition title | Use for due date on or after January 25, 2025. |
| Opportunity pkgs 1 / Electronic required | Y |
| Opportunity pkgs 1 / Expected application count | 100 |
| Opportunity pkgs 1 / Open to applicant type | 1 |
| Opportunity pkgs 1 / Is multi project | N |
| Opportunity pkgs 1 / Extension | |
| Opportunity pkgs 1 / Mimetype | application/pdf |
| Opportunity pkgs 1 / Last update | Aug 31, 2026 10:20:52 AM EDT |
| Opportunity pkgs 1 / Workspace compatible flag | Y |
| Opportunity pkgs 1 / Package id | PKG00294084 |
| Opportunity pkgs 1 / Opening date str | 2026-10-09-00-00-00 |
| Opportunity pkgs 1 / Closing date str | 2026-11-09-00-00-00 |
| Closed opportunity pkgs | Not specified |
| Original due date | Nov 09, 2026 12:00:00 AM EST |
| Synopsis modified fields | Not specified |
| Forecast modified fields | revision; version; archiveDate; modComments; createTimeStamp |
| Error messages | Not specified |
| Syn post date in past | Yes |
| Doc type | synopsis |
| Forecast hist count | 0 |
| Synopsis hist count | 0 |
| Assist compatible | No |
| Assist url | Not specified |
| Related opps | Not specified |
| Ost | POSTED |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | Division of Diabetes, Endocrinology and Metabolic Diseases NIDDK_DEM@nih.gov |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.847 | FORMS-I | Use for due date on or after January 25, 2025. | PKG00294084 | 2026-10-09 | 2026-11-09 | View |
Package 1
Instructions
PKG00294120-instructions.pdf
Mandatory forms
RR_SF424_5_0-V5.0.pdf
PHS398_CoverPageSupplement_5_0-V5.0.pdf
RR_OtherProjectInfo_1_4-V1.4.pdf
PerformanceSite_4_0-V4.0.pdf
RR_KeyPersonExpanded_4_0-V4.0.pdf
PHS398_ResearchPlan_5_0-V5.0.pdf
PHSHumanSubjectsAndClinicalTrialsInfo_3_0-V3.0.pdf
Optional forms
RR_Budget_3_0-V3.0.pdf
RR_SubawardBudget30_3_0-V3.0.pdf
PHS398_ModularBudget_1_2-V1.2.pdf
PHS_AssignmentRequestForm_4_0-V4.0.pdf
